Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BSX

Boston Scientific Corp

Dec 13 • 04:00PM ET

90.11

Dollar change -0.31
Percentage change -0.34	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV VHT IWD IHI MTUM

Scroll to Statements

Index	S&P 500	P/E	74.53	EPS (ttm)	1.21	Insider Own	0.42%	Shs Outstand	1.47B	Perf Week	0.04%
Market Cap	132.35B	Forward P/E	32.25	EPS next Y	2.79	Insider Trans	-10.73%	Shs Float	1.47B	Perf Month	1.51%
Income	1.79B	PEG	5.25	EPS next Q	0.66	Inst Own	91.35%	Short Float	0.83%	Perf Quarter	7.90%
Sales	15.91B	P/S	8.32	EPS this Y	20.05%	Inst Trans	-0.38%	Short Ratio	2.11	Perf Half Y	17.39%
Book/sh	14.05	P/B	6.41	EPS next Y	13.54%	ROA	4.97%	Short Interest	12.25M	Perf Year	59.54%
Cash/sh	1.75	P/C	51.46	EPS next 5Y	14.20%	ROE	9.05%	52W Range	54.95 - 91.93	Perf YTD	55.87%
Dividend Est.	-	P/FCF	61.39	EPS past 5Y	-2.05%	ROI	5.91%	52W High	-1.98%	Beta	0.80
Dividend TTM	-	Quick Ratio	1.02	Sales past 5Y	8.10%	Gross Margin	62.41%	52W Low	63.99%	ATR (14)	1.47
Dividend Ex-Date	-	Current Ratio	1.48	EPS Y/Y TTM	48.36%	Oper. Margin	16.49%	RSI (14)	55.09	Volatility	1.51% 1.69%
Employees	48000	Debt/Eq	0.54	Sales Y/Y TTM	15.65%	Profit Margin	11.26%	Recom	1.49	Target Price	99.89
Option/Short	Yes / Yes	LT Debt/Eq	0.46	EPS Q/Q	-7.91%	Payout	0.00%	Rel Volume	0.55	Prev Close	90.42
Sales Surprise	4.16%	EPS Surprise	7.09%	Sales Q/Q	19.34%	Earnings	Oct 23 BMO	Avg Volume	5.81M	Price	90.11
SMA20	-0.03%	SMA50	2.56%	SMA200	15.16%	Trades		Volume	3,181,488	Change	-0.34%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51
Apr-15-21	Initiated	Atlantic Equities	Overweight	$52
Sep-17-20	Initiated	Truist	Buy	$47

Show Previous Ratings

Dec-13-24 11:10PM	Jim Cramer on Boston Scientific Corporation (BSX): A Superior Company (Insider Monkey)
09:30AM	Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Dec-11-24 06:00PM	Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
08:08AM	Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace (PR Newswire)
Dec-05-24 06:00PM	Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
09:30AM	Loading…
Nov-26-24 09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
07:05AM	Boston Scientific to acquire Intera Oncology, terms not disclosed (TipRanks)
Nov-25-24 12:16PM	Boston Scientific expands infusion offerings with Intera Oncology acquisition (Medical Device Network)
07:00AM	Boston Scientific Announces Agreement to Acquire Intera Oncology Inc. (PR Newswire)
06:46AM	Boston Scientific to buy Intera Oncology, maker of liver cancer treatment (MedTech Dive)
Nov-22-24 11:30AM	Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report? (Zacks)
Nov-20-24 10:20AM	Boston Scientific Corporation (BSX)s Breakthroughs: A Hidden Gem in Billionaire Ken Griffins Portfolio (Insider Monkey)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
06:57AM	Boston Scientifics Watchman could be new option for patients post ablation: study (MedTech Dive)
06:48AM	The PFA race is heating up. Heres where the market stands after J&Js approval. (MedTech Dive)
04:36AM	Loading…
04:36AM	Boston Scientific reports outcomes from trial of LAAC device (Medical Device Network)
Nov-16-24 03:07PM	Boston Scientific WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial (PR Newswire)
Nov-15-24 08:43AM	Boston Scientific Closes Acquisition of Axonics, Inc. (PR Newswire)
06:46AM	Boston Scientific closes $3.7B Axonics deal after lengthy review (MedTech Dive)
Nov-14-24 09:09PM	Strategic Moves in Caxton Associates' Portfolio Highlight Tesla's Prominence (GuruFocus.com)
09:30AM	SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors (PR Newswire)
Nov-12-24 06:11AM	Boston Scientific resumes PFA trial in new patient group after pausing enrollment (MedTech Dive)
Nov-11-24 08:14AM	Boston Scientific resumes enrolment in pulsed field ablation trial (Clinical Trials Arena)
Nov-09-24 10:24AM	Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now (Insider Monkey)
09:46AM	Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds (Insider Monkey)
Nov-07-24 06:35AM	J&J wins FDA approval for Varipulse PFA system (MedTech Dive)
Nov-05-24 08:00AM	Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference (PR Newswire)
07:09AM	Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition (Medical Device Network)
Nov-04-24 07:39AM	Boston Scientific continues M&A run with Cortex buy (MedTech Dive)
06:55AM	Boston Scientific Announces Agreement to Acquire Cortex, Inc. (PR Newswire)
12:07PM	Loading…
Nov-03-24 12:07PM	Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth (Insider Monkey)
Nov-02-24 01:06AM	Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX) (GuruFocus.com)
Nov-01-24 09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
Oct-31-24 12:45PM	Looking for a Growth Stock? 3 Reasons Why Boston Scientific (BSX) is a Solid Choice (Zacks)
06:00AM	Boston Scientifics Acurate Neo2 inferior to rival TAVR valves in study (MedTech Dive)
Oct-30-24 03:08PM	Why is Boston Scientific Stock Trading Lower On Wednesday? (Benzinga)
11:41AM	ACURATE neo2 Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 (PR Newswire)
Oct-28-24 12:04PM	Boston Scientific to close Silk Road Medical headquarters, lay off 138 people (MedTech Dive)
10:58AM	Boston Scientific Halts Key Trial for FARAPULSE System Amid Unexpected Complications (GuruFocus.com)
Oct-25-24 09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
06:00AM	Medtronic wins FDA approval for Affera mapping and ablation system (MedTech Dive)
Oct-24-24 03:04AM	Boston Scientific Corp (BSX) Q3 2024 Earnings Call Highlights: Robust Growth and Strategic ... (GuruFocus.com)
03:00AM	Q3 2024 Boston Scientific Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-23-24 07:10PM	Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm (Benzinga)
04:06PM	Boston Scientific's Rockstar Segment Just Fumbled And So Did Its Shares (Investor's Business Daily)
02:42PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
01:09PM	Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges (Investopedia)
12:05PM	Boston Scientific Faces Trial Setback, But This Game-Changing Growth Surge Could Ignite the Stock (GuruFocus.com)
10:16AM	Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices (Benzinga)
10:00AM	Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics (Zacks)
09:39AM	Boston Scientific Pulls Back From Record-High Ambitions Despite Third-Quarter Sweep (Investor's Business Daily)
09:30AM	Boston Scientific price target raised to $100 from $90 at BofA (TipRanks)
07:40AM	Boston Scientific (BSX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:07AM	Boston Scientific Boosts FY24 Outlook - Update (RTT News)
06:55AM	Boston Scientific raises annual earnings forecast, shares rise (Investing.com)
06:54AM	Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High (Investor's Business Daily)
06:38AM	Boston Scientific: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Boston Scientific Announces Results for Third Quarter 2024 (PR Newswire)
Oct-22-24 01:13AM	Boston Scientific, Edwards and Dexcom usher in second week of earnings (MedTech Dive)
Oct-21-24 12:38PM	FDA greenlights add-ons for Boston Scientifics Farapulse field ablation system (Medical Device Network)
06:59AM	Boston Scientific wins FDA approval for Farapulse cardiac mapping (MedTech Dive)
01:29AM	Boston Scientific blood-blocking agent tied to additional 2 deaths, 8 injuries (MedTech Dive)
Oct-19-24 04:05PM	Boston Scientific launches next-gen cardiac mapping for FARAPULSE (TipRanks)
Oct-18-24 04:23PM	Needham Downgrades Boston Scientific Over Watchman Growth Concerns and Uncertain Trial Outcomes (GuruFocus.com)
04:01PM	Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE Pulsed Field Ablation System (PR Newswire)
09:15AM	Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
08:27AM	Boston Scientific stock down as Needham cuts to Hold on growth concerns (Investing.com)
Oct-16-24 06:00PM	Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
11:32AM	Boston Scientific: evolving the cardiac rhythm management space (Medical Device Network)
10:01AM	Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-15-24 04:01PM	Solventum Stock Earns 81 RS Rating (Investor's Business Daily)
12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX) (Zacks)
09:15AM	Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue? (Zacks)
Oct-10-24 06:15PM	Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Oct-09-24 09:40AM	Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-08-24 09:30AM	Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? (Zacks)
Oct-04-24 06:00PM	Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Oct-02-24 06:15PM	Why Boston Scientific (BSX) Outpaced the Stock Market Today (Zacks)
08:00AM	Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results (PR Newswire)
Sep-30-24 11:08AM	Boston Scientific Corporation (BSX) Surged on Excitement Over the Launch of its Ablation System (Insider Monkey)
04:52AM	Boston Scientifics Farapulse PFA system receives approval in Japan (Medical Device Network)
04:50AM	Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth (Insider Monkey)
Sep-28-24 01:21PM	7 Best Dialysis and Kidney Disease Stocks to Buy (Insider Monkey)
Sep-27-24 07:00AM	Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE Pulsed Field Ablation System (PR Newswire)
Sep-26-24 06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Sep-23-24 06:15PM	Boston Scientific (BSX) Rises But Trails Market: What Investors Should Know (Zacks)
Sep-20-24 12:45PM	Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
12:00PM	Boston Scientific (BSX) Is Up 2.10% in One Week: What You Should Know (Zacks)
11:54AM	Medtronics Aurora EV-ICD to challenge Boston Scientifics S-ICD market leadership (Medical Device Network)
09:30AM	Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? (Zacks)
09:15AM	Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Sep-19-24 08:02AM	Jury sides with Axonics in Medtronic patent dispute (MedTech Dive)
Sep-18-24 09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
Sep-17-24 06:00PM	Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
12:34PM	Boston Scientific expands FDA label for Ingevity+ pacing leads (Medical Device Network)
08:31AM	Boston Scientific Closes Acquisition of Silk Road Medical, Inc. (PR Newswire)
07:00AM	Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area (PR Newswire)
Sep-16-24 08:03PM	Boston Scientific Corporation (BSX): Among Morgan Stanley's Best Stock Picks for 2025 (Insider Monkey)
Sep-13-24 08:10AM	Boston Scientific, Silk Road expect to close merger in coming days (MedTech Dive)
Sep-11-24 06:00PM	Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carruthers Wendy	EVP, Human Resources	Dec 02 '24	Option Exercise	19.31	4,263	82,306	36,291	Dec 04 04:13 PM
Carruthers Wendy	EVP, Human Resources	Dec 02 '24	Sale	90.78	6,983	633,917	29,308	Dec 04 04:13 PM
Woodworth Emily	SVP, Global Controller and CAO	Nov 27 '24	Sale	90.65	1,336	121,105	2,957	Dec 02 04:46 PM
WENDY CARRUTHERS	Officer	Dec 02 '24	Proposed Sale	90.78	6,983	633,917		Dec 02 04:02 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Nov 25 '24	Option Exercise	21.40	4,186	89,565	14,988	Nov 25 05:46 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Nov 25 '24	Sale	89.27	14,010	1,250,664	978	Nov 25 05:46 PM
ARTHUR C BUTCHER	Officer	Nov 25 '24	Proposed Sale	89.27	14,010	1,250,663		Nov 25 04:06 PM
LUDWIG EDWARD J	Director	Nov 21 '24	Sale	91.63	4,877	446,902	39,398	Nov 22 05:22 PM
LUDWIG EDWARD J	Director	Nov 21 '24	Proposed Sale	91.63	4,877	446,902		Nov 21 04:58 PM
Sorenson John Bradley	EVP, Global Operations	Nov 08 '24	Option Exercise	24.55	17,362	426,237	70,286	Nov 12 05:41 PM
Sorenson John Bradley	EVP, Global Operations	Nov 08 '24	Sale	87.66	30,580	2,680,572	39,706	Nov 12 05:41 PM
JOHN B SORENSON	Officer	Nov 08 '24	Proposed Sale	87.66	30,580	2,680,569		Nov 08 04:23 PM
Mahoney Michael F	Chairman, President & CEO	Nov 05 '24	Option Exercise	16.79	111,887	1,878,277	1,683,983	Nov 07 04:45 PM
Mahoney Michael F	Chairman, President & CEO	Nov 05 '24	Sale	84.75	162,778	13,794,851	1,521,205	Nov 07 04:45 PM
MICHAEL F MAHONEY	Officer	Nov 05 '24	Proposed Sale	84.75	162,778	13,794,843		Nov 05 04:18 PM
Carruthers Wendy	EVP, Human Resources	Nov 01 '24	Option Exercise	19.31	4,263	82,306	39,011	Nov 04 04:09 PM
Carruthers Wendy	EVP, Human Resources	Nov 01 '24	Sale	84.33	6,983	588,876	32,028	Nov 04 04:09 PM
WENDY CARRUTHERS	Officer	Nov 01 '24	Proposed Sale	84.33	6,983	588,876		Nov 01 04:27 PM
Mahoney Michael F	Chairman, President & CEO	Oct 07 '24	Option Exercise	16.79	111,886	1,878,261	1,734,873	Oct 08 05:48 PM
Mahoney Michael F	Chairman, President & CEO	Oct 07 '24	Sale	84.63	162,777	13,775,792	1,572,096	Oct 08 05:48 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 07 '24	Option Exercise	21.07	116,639	2,458,000	292,994	Oct 08 05:48 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 07 '24	Sale	85.00	132,527	11,264,888	160,467	Oct 08 05:48 PM
JOSEPH M FITZGERALD	Officer	Oct 07 '24	Proposed Sale	85.00	132,527	11,264,890		Oct 07 04:16 PM
MICHAEL F MAHONEY	Officer	Oct 07 '24	Proposed Sale	84.63	162,777	13,775,785		Oct 07 04:10 PM
Carruthers Wendy	EVP, Human Resources	Oct 01 '24	Option Exercise	19.31	4,263	82,306	41,731	Oct 02 04:22 PM
Carruthers Wendy	EVP, Human Resources	Oct 01 '24	Sale	83.86	6,983	585,594	34,748	Oct 02 04:22 PM
WENDY CARRUTHERS	Officer	Oct 01 '24	Proposed Sale	83.86	6,983	585,594		Oct 01 04:05 PM
Mahoney Michael F	Chairman, President & CEO	Sep 05 '24	Option Exercise	16.79	111,886	1,878,261	1,785,764	Sep 06 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Sep 05 '24	Sale	81.17	162,777	13,212,544	1,622,987	Sep 06 04:12 PM
MICHAEL F MAHONEY	Officer	Sep 05 '24	Proposed Sale	81.17	162,777	13,212,533		Sep 05 04:03 PM
Carruthers Wendy	EVP, Human Resources	Sep 03 '24	Option Exercise	19.31	4,263	82,306	44,451	Sep 03 05:29 PM
Carruthers Wendy	EVP, Human Resources	Sep 03 '24	Sale	81.70	6,983	570,511	37,468	Sep 03 05:29 PM
WENDY CARRUTHERS	Officer	Sep 03 '24	Proposed Sale	81.70	6,983	570,511		Sep 03 04:06 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 28 '24	Sale	80.00	14,132	1,130,560	176,355	Aug 29 04:13 PM
JOSEPH M FITZGERALD	Officer	Aug 28 '24	Proposed Sale	80.00	14,132	1,130,560		Aug 28 04:21 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 26 '24	Option Exercise	21.40	4,185	89,542	24,814	Aug 26 04:32 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 26 '24	Sale	79.25	14,012	1,110,515	10,802	Aug 26 04:32 PM
ARTHUR C BUTCHER	Officer	Aug 26 '24	Proposed Sale	79.25	14,012	1,110,514		Aug 26 04:02 PM
Carruthers Wendy	EVP, Human Resources	Aug 01 '24	Option Exercise	19.31	4,263	82,306	47,171	Aug 01 05:13 PM
Carruthers Wendy	EVP, Human Resources	Aug 01 '24	Sale	74.12	6,983	517,580	40,188	Aug 01 05:13 PM
WENDY CARRUTHERS	Officer	Aug 01 '24	Proposed Sale	74.12	6,983	517,580		Aug 01 04:14 PM
Carruthers Wendy	EVP, Human Resources	Jul 01 '24	Option Exercise	19.31	4,263	82,306	49,891	Jul 02 04:13 PM
Carruthers Wendy	EVP, Human Resources	Jul 01 '24	Sale	77.30	6,983	539,786	42,908	Jul 02 04:13 PM
Carruthers Wendy	EVP, Human Resources	Jun 03 '24	Option Exercise	19.31	4,263	82,306	52,611	Jun 03 05:39 PM
Carruthers Wendy	EVP, Human Resources	Jun 03 '24	Sale	75.33	6,983	526,029	45,628	Jun 03 05:39 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	May 29 '24	Option Exercise	17.26	33,726	582,111	91,824	May 30 04:27 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	May 29 '24	Sale	75.10	63,802	4,791,447	28,022	May 30 04:27 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 28 '24	Option Exercise	21.40	4,186	89,565	34,208	May 29 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 28 '24	Sale	75.34	14,011	1,055,590	20,197	May 29 05:04 PM
Brennan Daniel J.	EVP and CFO	May 22 '24	Option Exercise	21.33	64,454	1,374,836	335,996	May 23 04:12 PM
Brennan Daniel J.	EVP and CFO	May 22 '24	Sale	75.91	64,454	4,892,819	271,542	May 23 04:12 PM
Brennan Daniel J.	EVP and CFO	May 23 '24	Sale	75.11	47,621	3,576,932	223,921	May 23 04:12 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '24	Option Exercise	24.55	18,037	442,808	50,363	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 22 '24	Option Exercise	27.09	15,006	406,513	47,332	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '24	Sale	75.60	18,037	1,363,606	32,326	May 23 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 22 '24	Sale	76.01	15,006	1,140,633	32,326	May 23 04:11 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 10 '24	Option Exercise	16.31	12,931	210,905	44,353	May 13 04:41 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 10 '24	Sale	74.14	12,931	958,717	31,422	May 13 04:41 PM
Dockendorff Charles J	Director	May 07 '24	Sale	72.70	3,946	286,874	0	May 08 04:11 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '24	Option Exercise	0.00	4,203	0	54,841	May 06 04:18 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '24	Option Exercise	0.00	2,102	0	31,039	May 06 04:17 PM
Sorenson John Bradley	EVP, Global Operations	May 01 '24	Option Exercise	17.26	17,587	303,552	68,225	May 02 04:46 PM
Sorenson John Bradley	EVP, Global Operations	May 01 '24	Sale	71.50	17,587	1,257,488	50,638	May 02 04:46 PM
Carruthers Wendy	EVP, Human Resources	May 01 '24	Option Exercise	19.31	4,263	82,306	55,331	May 02 04:42 PM
Carruthers Wendy	EVP, Human Resources	May 01 '24	Sale	71.47	6,983	499,075	48,348	May 02 04:42 PM
LUDWIG EDWARD J	Director	Apr 26 '24	Option Exercise	17.37	9,818	170,539	51,192	Apr 29 04:12 PM
LUDWIG EDWARD J	Director	Apr 26 '24	Sale	73.29	9,818	719,562	41,374	Apr 29 04:12 PM
Sorenson John Bradley	EVP, Global Operations	Apr 01 '24	Option Exercise	16.31	16,351	266,685	66,989	Apr 02 06:57 PM
Sorenson John Bradley	EVP, Global Operations	Apr 01 '24	Sale	69.30	16,351	1,133,069	50,638	Apr 02 06:57 PM
Carruthers Wendy	EVP, Human Resources	Apr 01 '24	Option Exercise	19.31	4,263	82,306	58,051	Apr 02 06:57 PM
Carruthers Wendy	EVP, Human Resources	Apr 01 '24	Sale	68.42	6,983	477,777	51,068	Apr 02 06:57 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Mar 18 '24	Sale	66.45	14,506	963,930	58,098	Mar 19 04:41 PM
Carruthers Wendy	EVP, Human Resources	Mar 01 '24	Option Exercise	19.31	4,263	82,306	60,771	Mar 04 06:50 PM
Carruthers Wendy	EVP, Human Resources	Mar 01 '24	Sale	66.35	6,983	463,322	53,788	Mar 04 06:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 26 '24	Option Exercise	21.40	4,185	89,542	38,272	Feb 27 04:19 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 26 '24	Sale	67.07	9,335	626,098	28,937	Feb 27 04:19 PM
Carruthers Wendy	EVP, Human Resources	Feb 23 '24	Option Exercise	19.31	4,263	82,306	63,491	Feb 26 04:13 PM
Carruthers Wendy	EVP, Human Resources	Feb 23 '24	Sale	66.89	6,983	467,093	56,508	Feb 26 04:13 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 21 '24	Sale	66.35	4,960	329,096	72,604	Feb 22 04:19 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 18 '24	Option Exercise	0.00	2,002	0	31,204	Feb 20 09:05 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 17 '24	Option Exercise	0.00	2,500	0	30,650	Feb 20 09:05 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 16 '24	Option Exercise	0.00	2,263	0	29,461	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '24	Option Exercise	0.00	1,186	0	51,179	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '24	Option Exercise	0.00	1,500	0	50,678	Feb 20 09:05 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '24	Option Exercise	0.00	1,273	0	49,759	Feb 20 09:05 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 18 '24	Option Exercise	0.00	638	0	38,240	Feb 20 09:04 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 17 '24	Option Exercise	0.00	1,000	0	38,006	Feb 20 09:04 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 16 '24	Option Exercise	0.00	990	0	37,433	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 18 '24	Option Exercise	0.00	2,817	0	78,849	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '24	Option Exercise	0.00	3,333	0	77,552	Feb 20 09:04 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '24	Option Exercise	0.00	2,970	0	75,574	Feb 20 09:04 PM
Carruthers Wendy	EVP, Human Resources	Feb 18 '24	Option Exercise	0.00	1,853	0	63,100	Feb 20 09:03 PM
Carruthers Wendy	EVP, Human Resources	Feb 17 '24	Option Exercise	0.00	2,250	0	62,245	Feb 20 09:03 PM
Carruthers Wendy	EVP, Human Resources	Feb 16 '24	Option Exercise	0.00	2,051	0	60,905	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 18 '24	Option Exercise	0.00	16,307	0	1,681,111	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '24	Option Exercise	0.00	18,333	0	1,672,935	Feb 20 09:03 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '24	Option Exercise	0.00	16,265	0	1,661,816	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 18 '24	Option Exercise	0.00	2,372	0	35,139	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '24	Option Exercise	0.00	2,833	0	34,024	Feb 20 09:03 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '24	Option Exercise	0.00	2,546	0	32,321	Feb 20 09:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience